(Updated - June 4, 2021 6:19 AM EDT)

Citi analyst Yigal Nochomovitz upgraded Mirati Therapeutics (NASDAQ: MRTX) from Neutral ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE